FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2594950887> ?p ?o ?g. }

• W2594950887 endingPage "1042" @default.
• W2594950887 startingPage "1042" @default.
• W2594950887 abstract "Abstract Background. Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired blood disease, characterized by hemolytic anemia, bone marrow (BM) failure, and venous thrombosis. The etiology of PNH is a somatic mutation in the phosphatidylinositol glycan class A gene (PIG-A) on the X chromosome, which causes deficiency in glycosyl phosphatidylinositol-anchored proteins (GPI-APs). The involvement of T cells in PNH is strongly supported by clinical overlap between PNH and aplastic anemia (AA); the presence of GPI-AP deficient cells in AA associated with favorable response to immunosuppressive therapy; and an oligoclonal T cell repertoire in PNH patients. However, the molecular mechanisms responsible for the aberrant immune responses in PNH patients are not well understood. To identify aberrant molecular mechanisms involved in immune targeting of hematopoietic stem cells in BM, RNA sequencing (RNA-seq) was applied to examine the transcriptome of T cell subsets from PNH patients and healthy controls. Method. Blood samples were obtained after informed consent from 15 PNH patients and 15 age-matched healthy controls. For RNA extraction, freshly isolated peripheral blood mononuclear cells were sorted on the same day of blood draw to obtain four different T cell (CD3+ CD14- CD19- ViViD-) populations [CD4+ naïve (CD45RA+ CD45RO-), CD4+ memory (CD45RA- CD45RO+), CD8+ naïve (CD45RA+ CD45RO-), and CD8+ memory (CD45RA- CD45RO+) T cells] by fluorescence-activated cell sorter . RNA-Seq analysis from three PNH and three healthy controls was performed using the Illumina HiSeq™ 2000 platform. The Ingenuity® Pathway Analysis and Gene set enrichment analysis (GSEA) were employed to elucidate transcriptional pathways. RNA-seq data were validated by flow cytometry and quantitative real-time RT-PCR (RT-qPCR). Results and Discussion . Differentially expressed gene analysis of four T cell subsets showed distinct gene expression signatures in individual T cell subsets. In CD4+ naïve T cells, 11 gene expression levels were significantly different: five upregulated (including SRRM2 and TNFSF8) and six downregulated genes (including GIMAP6) (> 2 fold change, false discovery rate [FDR] < 0.05). In CD4+ memory T cells, 25 gene expression levels were significantly different: 15 upregulated (including JUND and TOB1) and 10 downregulated genes (including GIMAP4). In CD8+ naive T cells, only two gene expression levels were significantly different: upregulated CTSW and downregulated RPL9. In CD8+ memory T cells, seven gene expression levels were significantly different: two upregulated (CTSW and DPP4) and five downregulated genes (including SLC12A7). Further, differentially expressed gene analysis was performed by combining CD4+ naïve, CD4+ memory, CD8+ naïve, and CD8+ memory T cells from PNH or healthy controls, respectively. Out of 55 gene expression levels that were significantly different, 41 were upregulated (including TNFAIP3, JUN, JUND, TOB1, TNFSF8, and CD69) and 14 downregulated (including GIMAP4). By canonical pathways analysis, putative gene network interactions of differentially expressed genes were significantly enriched for canonical pathways of TNFR1, TNFR2, IL-17A, and CD27 signaling. By GSEA, the most significantly upregulated gene sets in CD4+ naïve, CD4+ memory, CD8+ naïve, and CD8+ memory T cells from PNH patients displayed gene signatures related to the IGF1 pathway, Pre-NOTCH expression and processing, AP-1 pathway, and ATF2 pathway, respectively. For validation of the RNA-seq data, we chose seven genes (TNFAIP3, JUN, JUND, TOB1, TNFSF8, CD69, and CTSW) because these are important mediators involved in regulation for T cells and dysregulation of these genes is associated with autoimmune diseases. Differential expression levels of TNFAIP3, JUN, and TOB1 were validated by RT-qPCR. By flow cytometry, higher expression of CD69 and TNFSF8 was confirmed in CD4+ and CD8+T cells from PNH compared to healthy controls. Conclusion. Using RNA-seq, we identified novel molecular mechanisms and pathways which may underlie the aberrant T cell immune status in PNH. Specific dysregulation of T cell intracellular signaling may contribute to BM failure and the inflammatory environment in PNH. Understanding these pathways may provide new therapeutic strategies to modulate T cell immune responses in BM failure. Disclosures Hosokawa: Aplastic Anemia and MDS International Foundation: Research Funding. Rios:GSK/Novartis: Research Funding. Weinstein:GSK/Novartis: Research Funding. Townsley:GSK/Novartis: Research Funding." @default.
• W2594950887 created "2017-03-23" @default.
• W2594950887 creator A5004581558 @default.
• W2594950887 creator A5022608819 @default.
• W2594950887 creator A5023542193 @default.
• W2594950887 creator A5024079940 @default.
• W2594950887 creator A5025683999 @default.
• W2594950887 creator A5072063614 @default.
• W2594950887 creator A5075319144 @default.
• W2594950887 creator A5078240953 @default.
• W2594950887 creator A5080201916 @default.
• W2594950887 creator A5081398715 @default.
• W2594950887 creator A5084059553 @default.
• W2594950887 date "2016-12-02" @default.
• W2594950887 modified "2023-10-16" @default.
• W2594950887 title "T Cell Transcriptomes from Paroxysmal Nocturnal Hemoglobinuria Patients Reveal Novel Signaling Pathways" @default.
• W2594950887 doi "https://doi.org/10.1182/blood.v128.22.1042.1042" @default.
• W2594950887 hasPublicationYear "2016" @default.
• W2594950887 type Work @default.
• W2594950887 sameAs 2594950887 @default.
• W2594950887 citedByCount "0" @default.
• W2594950887 crossrefType "journal-article" @default.
• W2594950887 hasAuthorship W2594950887A5004581558 @default.
• W2594950887 hasAuthorship W2594950887A5022608819 @default.
• W2594950887 hasAuthorship W2594950887A5023542193 @default.
• W2594950887 hasAuthorship W2594950887A5024079940 @default.
• W2594950887 hasAuthorship W2594950887A5025683999 @default.
• W2594950887 hasAuthorship W2594950887A5072063614 @default.
• W2594950887 hasAuthorship W2594950887A5075319144 @default.
• W2594950887 hasAuthorship W2594950887A5078240953 @default.
• W2594950887 hasAuthorship W2594950887A5080201916 @default.
• W2594950887 hasAuthorship W2594950887A5081398715 @default.
• W2594950887 hasAuthorship W2594950887A5084059553 @default.
• W2594950887 hasBestOaLocation W25949508871 @default.
• W2594950887 hasConcept C167672396 @default.
• W2594950887 hasConcept C203014093 @default.
• W2594950887 hasConcept C2777346216 @default.
• W2594950887 hasConcept C86803240 @default.
• W2594950887 hasConcept C8891405 @default.
• W2594950887 hasConceptScore W2594950887C167672396 @default.
• W2594950887 hasConceptScore W2594950887C203014093 @default.
• W2594950887 hasConceptScore W2594950887C2777346216 @default.
• W2594950887 hasConceptScore W2594950887C86803240 @default.
• W2594950887 hasConceptScore W2594950887C8891405 @default.
• W2594950887 hasIssue "22" @default.
• W2594950887 hasLocation W25949508871 @default.
• W2594950887 hasLocation W25949508872 @default.
• W2594950887 hasOpenAccess W2594950887 @default.
• W2594950887 hasPrimaryLocation W25949508871 @default.
• W2594950887 hasRelatedWork W154110903 @default.
• W2594950887 hasRelatedWork W2056075233 @default.
• W2594950887 hasRelatedWork W2056385328 @default.
• W2594950887 hasRelatedWork W2220102944 @default.
• W2594950887 hasRelatedWork W2577548098 @default.
• W2594950887 hasRelatedWork W3007075535 @default.
• W2594950887 hasRelatedWork W3031852375 @default.
• W2594950887 hasRelatedWork W3112940496 @default.
• W2594950887 hasRelatedWork W4241494942 @default.
• W2594950887 hasRelatedWork W4244918447 @default.
• W2594950887 hasVolume "128" @default.
• W2594950887 isParatext "false" @default.
• W2594950887 isRetracted "false" @default.
• W2594950887 magId "2594950887" @default.
• W2594950887 workType "article" @default.